Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 11/2006

01.11.2006 | Article

Prevalence of respiratory viruses, including newly identified viruses, in hospitalised children in Austria

verfasst von: C. Larcher, V. Jeller, H. Fischer, H. P. Huemer

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

The aim of this epidemiological study was to determine the prevalence of respiratory viruses, including new viruses, in hospitalised children in Austria. Two hundred fourteen nasopharyngeal samples from hospitalised children were tested for the presence of viruses using cell culture and PCR and/or viral antigen assays. The results revealed a parainfluenza virus 1 (PIV1) outbreak that ended right before the onset of the influenza season, with nearly no overlapping, moderate respiratory syncytial virus (RSV) activity, and only a few adenoviruses. Human metapneumovirus (hMPV) was present in 14.5% of the total samples but was detected in combination with other viruses in only five cases: with PIV1 in three cases and with RSV in two cases. There were no cases of dual infection with hMPV and flu or adenovirus. This suggests that hMPV alone is a leading cause of hospitalisation in children under 1 year of age. Interestingly, hMPV, in contrast to RSV, coincided with PIV1 but was absent during the community outbreak of the flu. Samples were also tested for Mimiviridae, a group of newly described DNA viruses that are similar to Legionella spp., replicate in water amoebae, and also have been found in alveolar cells. However, mimivirus was detected neither in respiratory samples nor in amoebae-containing water samples, indicating that this particular type of virus is either not abundant or does not contribute to paediatric respiratory illnesses.
Literatur
1.
Zurück zum Zitat Jartti T, Lehtinen P, Vuorinen T, Koskenvuo M, Ruuskanen O (2004) Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 72:695–699PubMedCrossRef Jartti T, Lehtinen P, Vuorinen T, Koskenvuo M, Ruuskanen O (2004) Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 72:695–699PubMedCrossRef
2.
Zurück zum Zitat Schwarze J, O’Donnell DR, Rohwedder A, Openshaw PJ (2004) Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 169:801–805PubMedCrossRef Schwarze J, O’Donnell DR, Rohwedder A, Openshaw PJ (2004) Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 169:801–805PubMedCrossRef
3.
Zurück zum Zitat Bosis S, Esposito S, Niesters HG, Crovari P, Osterhaus AD, Principi N (2005) Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J Med Virol 75:101–104PubMedCrossRef Bosis S, Esposito S, Niesters HG, Crovari P, Osterhaus AD, Principi N (2005) Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J Med Virol 75:101–104PubMedCrossRef
4.
Zurück zum Zitat Viazov S, Ratjen F, Scheidhauer R, Fiedler M, Roggendorf M (2003) High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J Clin Microbiol 41:3043–3045PubMedCrossRef Viazov S, Ratjen F, Scheidhauer R, Fiedler M, Roggendorf M (2003) High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J Clin Microbiol 41:3043–3045PubMedCrossRef
5.
Zurück zum Zitat König B, König W, Arnold R, Werchau H, Ihorst G, Forster J (2004) Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol 42:4632–4635PubMedCrossRef König B, König W, Arnold R, Werchau H, Ihorst G, Forster J (2004) Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol 42:4632–4635PubMedCrossRef
6.
Zurück zum Zitat Wilkesmann A, Schildgen O, Eis-Hubinger AM, Geikowski T, Glatzel T, Lentze MJ, Bode U, Simon A (2006) Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr 165:467–475PubMedCrossRef Wilkesmann A, Schildgen O, Eis-Hubinger AM, Geikowski T, Glatzel T, Lentze MJ, Bode U, Simon A (2006) Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr 165:467–475PubMedCrossRef
7.
Zurück zum Zitat LaScola B, Marrie TJ, Auffray JP, Raoult D (2005) Mimivirus in pneumonia patients. Emerg Infect Dis 11:449–452 LaScola B, Marrie TJ, Auffray JP, Raoult D (2005) Mimivirus in pneumonia patients. Emerg Infect Dis 11:449–452
8.
Zurück zum Zitat Chan PK, Tam JS, Lam CW, Chan E, Wu A, Li CK, Buckley TA, Ng KC, Joynt GM, Cheng FW, To KF, Lee N, Hui DS, Cheung JL, Chu I, Liu E, Chung SS, Sung JJ (2003) Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 9:1058–1063PubMed Chan PK, Tam JS, Lam CW, Chan E, Wu A, Li CK, Buckley TA, Ng KC, Joynt GM, Cheng FW, To KF, Lee N, Hui DS, Cheung JL, Chu I, Liu E, Chung SS, Sung JJ (2003) Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 9:1058–1063PubMed
9.
Zurück zum Zitat Gröndahl B, Puppe W, Hoppe A, Kuhne I, Weigl JA, Schmitt HJ (1999) Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin Microbiol 37:1–7PubMed Gröndahl B, Puppe W, Hoppe A, Kuhne I, Weigl JA, Schmitt HJ (1999) Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin Microbiol 37:1–7PubMed
10.
Zurück zum Zitat Maertzdorf J, Wang CK, Brown JB, Quinto JD, Chu M, de Graaf M, van den Hoogen BG, Spaete R, Osterhaus AD, Fouchier RA (2004) Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol 42:981–986PubMedCrossRef Maertzdorf J, Wang CK, Brown JB, Quinto JD, Chu M, de Graaf M, van den Hoogen BG, Spaete R, Osterhaus AD, Fouchier RA (2004) Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol 42:981–986PubMedCrossRef
11.
Zurück zum Zitat Raoult D, Aboudharam G, Crubezy E, Larrouy G, Ludes B, Drancourt M (2000) Molecular identification by “suicide PCR” of Yersinia pestis as the agent of medieval black death. Proc Natl Acad Sci USA 97:12800–12803PubMedCrossRef Raoult D, Aboudharam G, Crubezy E, Larrouy G, Ludes B, Drancourt M (2000) Molecular identification by “suicide PCR” of Yersinia pestis as the agent of medieval black death. Proc Natl Acad Sci USA 97:12800–12803PubMedCrossRef
12.
Zurück zum Zitat Noyola DE, Alpuche-Solis AG, Herrera-Diaz A, Soria-Guerra RE, Sanchez-Alvarado J, Lopez-Revilla R (2005) Human metapneumovirus infections in Mexico: epidemiological and clinical characteristics. J Med Microbiol 54:969–974PubMedCrossRef Noyola DE, Alpuche-Solis AG, Herrera-Diaz A, Soria-Guerra RE, Sanchez-Alvarado J, Lopez-Revilla R (2005) Human metapneumovirus infections in Mexico: epidemiological and clinical characteristics. J Med Microbiol 54:969–974PubMedCrossRef
13.
Zurück zum Zitat Glezen WP (2004) The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures. Pediatr Infect Dis J 23 (Suppl 11):S202–S206PubMed Glezen WP (2004) The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures. Pediatr Infect Dis J 23 (Suppl 11):S202–S206PubMed
14.
Zurück zum Zitat Larcher C, Geltner C, Fischer H, Nachbaur D, Müller LC, Huemer HP (2005) Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 24:1891–1901PubMedCrossRef Larcher C, Geltner C, Fischer H, Nachbaur D, Müller LC, Huemer HP (2005) Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 24:1891–1901PubMedCrossRef
15.
Zurück zum Zitat Bassetti S, Bischoff WE, Sherertz RJ (2005) Are SARS superspreaders cloud adults? Emerg Infect Dis 11:637–638PubMed Bassetti S, Bischoff WE, Sherertz RJ (2005) Are SARS superspreaders cloud adults? Emerg Infect Dis 11:637–638PubMed
Metadaten
Titel
Prevalence of respiratory viruses, including newly identified viruses, in hospitalised children in Austria
verfasst von
C. Larcher
V. Jeller
H. Fischer
H. P. Huemer
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2006
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0214-z

Weitere Artikel der Ausgabe 11/2006

European Journal of Clinical Microbiology & Infectious Diseases 11/2006 Zur Ausgabe

Announcements

Announcements

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.